The North America allergy immunotherapy market is expanding as the prevalence of allergic conditions and demand for targeted, long-term treatment continue to rise. Established healthcare systems, growing acceptance of sublingual immunotherapy, and ongoing development of novel allergy treatments are supporting wider adoption across the region. The Allergy Immunotherapy Market was valued at US$...